Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial

- Fernández-Cuesta, Lynnette; Oakman, Catherine; Larsimont, Denis; Francis, Prudence A.; Crown, John; Piccart-Gebhart, Martine; Viale, Giuseppe; Leo, Angelo Di; Olivier, Magali; Falagan-Lotsch, Patricia; Smoth, Ke-seay; Quinaux, Emmanuel; Buyse, Marc; Dolci, M. Stella; Azambuja, Evandro De; Hainaut, Pierre; Dell'Orto, Patrizia